Immune Checkpoint Inhibitor-Associated Colitis and Hepatitis

Immune checkpoint inhibitors (ICPIs) are monoclonal antibodies that target downregulators of the anti-cancer immune response: cytotoxic T-lymphocyte antigen-4, programmed cell death protein-1, and its ligand PD-L1. ICPIs are now approved for the treatment of a wide array of malignancies, with rates...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Haritha G., Schneider, Bryan J., Tai, Andrew W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143593/
https://www.ncbi.nlm.nih.gov/pubmed/30228268
http://dx.doi.org/10.1038/s41424-018-0049-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143593/
https://www.ncbi.nlm.nih.gov/pubmed/30228268
http://dx.doi.org/10.1038/s41424-018-0049-9

Ejemplares similares